Interest and Utility of MC1R Testing for Melanoma Risk in Dermatology Patients with a History of Nonmelanoma Skin Cancer
Public access to genetic information is increasing, and community dermatologists may progressively encounter patients interested in genetic testing for melanoma risk. Clarifying potential utility will help plan for this inevitability. We determined interest and uptake of genetic risk feedback based...
Saved in:
| Main Authors: | Jennifer L. Hay, Erica H. Lee, Stephanie N. Christian, Elizabeth Schofield, Jada G. Hamilton, Ciyu Yang, Bobak Hedayati, Keimya Sadeghi, Mark E. Robson, Allan Halpern, Liying Zhang, Irene Orlow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Skin Cancer |
| Online Access: | http://dx.doi.org/10.1155/2022/4046554 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botanical Agents for the Treatment of Nonmelanoma Skin Cancer
by: Jillian W. Millsop, et al.
Published: (2013-01-01) -
Daylight photodynamic therapy in nonmelanoma skin cancers and photorejuvenation
by: Paweł Pazdrowski, et al.
Published: (2025-01-01) -
Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
by: Mehdi Ghahartars, et al.
Published: (2018-01-01) -
Hydroxyurea and nonmelanoma skin cancers: Report of three cases and review of the literature
by: Roš Tatjana, et al.
Published: (2017-01-01) -
Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation
by: Nikolai Gräger, et al.
Published: (2019-01-01)